Women’s College Research Institute (WCRI) is Canada’s leading research institute dedicated to advancing health for women and delivering health system solutions for all. We’re here for women because we’re committed to the health of our whole society. Our commitment to the whole drives our work to create health system solutions that benefit us all.
Our growth in funding support in 2011-12 speaks to the increasing recognition of our pivotal role and far-reaching impact. Our achievements are anchored in our high-quality and community-engaged work, and our commitment to embed sex and gender-based analyses in all that we do.
In our Impact + Innovation report, we show you how Women’s College scientists nourish the roots of a healthy society, by improving health for women and supporting health system solutions that impact everyone. Through innovation in all that we do, our impact is leading a new way of understanding health care, and better health for everyone.
WCRI expert panel discusses sex and gender-based research
On Monday, October 22, Women’s College Hospital (WCH) and Women’s College Research Institute (WCRI) presented The POWER Study Forum: a discussion about cutting-edge issues in women’s health.
WCRI’s Dr. Steven Narod elected to Royal Society of Canada
Dr. Steven Narod, Canada Research Chair in Breast Cancer (Tier 1) and senior scientist at Women’s College Research Institute, has been elected as a fellow of the prestigious Royal Society of Canada (RSC). Narod, who is also a University of Toronto (U of T) professor in the Dalla Lana School of Public Health and the Department of Medicine, is one of 17 U of T faculty members elected.
For many mothers, postpartum depression does not resolve
“Postpartum depression does not resolve with time for a substantial number of mothers,” according to Dr. Cindy-Lee Dennis, Shirley Brown Chair in Women’s Mental Health Research at Women’s College Research Institute.
“Survivorship” care for women who haven’t had cancer
Women with BRCA mutations often have surgeries that are very effective at reducing their cancer risk. But hormone-altering surgery can also impact bone density and overall quality of life.
Genetic counselling at WCRI
Men who carry BRCA1/2 genetic mutations can pass the mutation to their children, even though male mutation carriers don’t face the same high cancer risk as women. Women with a BRCA mutation have a 70 to 80 per cent risk of getting breast cancer – often at a young age.
Clinicians must be aware of drug shortages
Between 2005 and 2010, the number of drugs that are in short supply has tripled. Around the world, many medications that have become a first line of defense for a wide variety of ailments are not always available. Dr. Paula Rochon, vice-president of research, Women’s College Hospital urges clinicians to take advantage of the expertise of other allied health professionals, particularly pharmacists, and work collaboratively to identify the best alternative treatment options.
Jump to top page
The Globe and Mail
The Globe and Mail
To sign up, click here